Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Rapastinel Trifluoroacetate

🥰Excellent
Catalog No. T5819Cas No. 1435786-04-1
Alias Thr-Pro-Pro-Thr-NH2 Trifluoroacetate, GLYX-13 Trifluoroacetate

Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with partial agonist properties at the glycine site.

Rapastinel Trifluoroacetate

Rapastinel Trifluoroacetate

🥰Excellent
Purity: 99.77%
Catalog No. T5819Alias Thr-Pro-Pro-Thr-NH2 Trifluoroacetate, GLYX-13 TrifluoroacetateCas No. 1435786-04-1
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with partial agonist properties at the glycine site.
Pack SizePriceAvailabilityQuantity
1 mg$33In Stock
5 mg$103In Stock
10 mg$173In Stock
25 mg$322In Stock
50 mg$442In Stock
100 mg$592In Stock
200 mg$783In Stock
1 mL x 10 mM (in DMSO)$118In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Rapastinel Trifluoroacetate"

Select Batch
Purity:99.77%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with partial agonist properties at the glycine site.
In vivo
Rapastinel Trifluoroacetate, a tetrapeptide (Thr-Pro-Pro-Thr-amide), has been reported to have fast acting antidepressant properties in man based upon its N-methyl-D-aspartate receptor (NMDAR) glycine site functional partial agonism.
Animal Research
C57BL/6J mice given a single dose or subchronic ketamine (30 mg/kg.i.p.) showed acute or persistent deficits in NOR, respectively.?Acute i.v. rapastinel (1.0 mg/kg), did not induce NOR deficit.?Pre-treatment with Rapastinel Trifluoroacetate?significantly prevented acute ketamine-induced NOR deficit.?Rapastinel Trifluoroacetate?(1.0 mg/kg, but not 0.3 mg/kg, iv) significantly reversed both subchronic ketamine- and subchronic PCP-induced NOR deficits.?Rapastinel Trifluoroacetate?also potentiated the atypical antipsychotic drug with antidepressant properties, lurasidone, to restore NOR in subchronic ketamine-treated mice.?Unlike ketamine,Rapastinel Trifluoroacetate?does not induce a declarative memory deficit in mice, and can prevent or reverse the ketamine-induced NOR deficit.?Further study is required to determine if these differences translate during clinical use of ketamine and rapastinel as fast acting antidepressant drugs and if rapastinel could have non-ionotropic effects as an add-on therapy with antipsychotic/antidepressant medications.
AliasThr-Pro-Pro-Thr-NH2 Trifluoroacetate, GLYX-13 Trifluoroacetate
Chemical Properties
Molecular Weight527.49
FormulaC20H32F3N5O8
Cas No.1435786-04-1
SmilesOC(=O)C(F)(F)F.C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 125 mg/mL (236.97 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8958 mL9.4789 mL18.9577 mL94.7885 mL
5 mM0.3792 mL1.8958 mL3.7915 mL18.9577 mL
10 mM0.1896 mL0.9479 mL1.8958 mL9.4789 mL
20 mM0.0948 mL0.4739 mL0.9479 mL4.7394 mL
50 mM0.0379 mL0.1896 mL0.3792 mL1.8958 mL
100 mM0.0190 mL0.0948 mL0.1896 mL0.9479 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Rapastinel Trifluoroacetate | purchase Rapastinel Trifluoroacetate | Rapastinel Trifluoroacetate cost | order Rapastinel Trifluoroacetate | Rapastinel Trifluoroacetate chemical structure | Rapastinel Trifluoroacetate in vivo | Rapastinel Trifluoroacetate formula | Rapastinel Trifluoroacetate molecular weight